rs148970492
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_004289.7(NFE2L3):c.1418G>A(p.Ser473Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000713 in 1,613,894 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S473T) has been classified as Benign.
Frequency
Consequence
NM_004289.7 missense
Scores
Clinical Significance
Conservation
Publications
- inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- oculopharyngeal muscular dystrophy 2Inheritance: AD Classification: STRONG Submitted by: G2P
- amyotrophic lateral sclerosisInheritance: AD Classification: MODERATE, LIMITED Submitted by: Genomics England PanelApp, ClinGen
- inclusion body myopathy with Paget disease of bone and frontotemporal dementiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152178Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000151 AC: 38AN: 251120 AF XY: 0.000125 show subpopulations
GnomAD4 exome AF: 0.0000732 AC: 107AN: 1461598Hom.: 0 Cov.: 33 AF XY: 0.0000536 AC XY: 39AN XY: 727102 show subpopulations
GnomAD4 genome AF: 0.0000525 AC: 8AN: 152296Hom.: 0 Cov.: 32 AF XY: 0.0000537 AC XY: 4AN XY: 74478 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1418G>A (p.S473N) alteration is located in exon 4 (coding exon 4) of the NFE2L3 gene. This alteration results from a G to A substitution at nucleotide position 1418, causing the serine (S) at amino acid position 473 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at